267 related articles for article (PubMed ID: 27805524)
21. Renal Papillary Carcinoma Developed in a Kidney Transplant Recipient With Late IgA-Nephropathy.
Melandro F; Guglielmo N; Nudo F; Pretagostini R; Mennini G; Poli L; Giannakakis K; Berloco PB
Exp Clin Transplant; 2016 Aug; 14(4):445-6. PubMed ID: 25184211
[TBL] [Abstract][Full Text] [Related]
22. Proteinuria among primarily sirolimus treated live-donor renal transplant recipients' long-term experience.
Hamdy AF; Bakr MA; Ghoneim MA
Exp Clin Transplant; 2010 Dec; 8(4):283-91. PubMed ID: 21143093
[TBL] [Abstract][Full Text] [Related]
23. Malignancies After Heart Transplant.
Lateef N; Abdul Basit K; Abbasi N; Kazmi SM; Ansari AB; Shah M
Exp Clin Transplant; 2016 Feb; 14(1):12-6. PubMed ID: 26643469
[TBL] [Abstract][Full Text] [Related]
24. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
[TBL] [Abstract][Full Text] [Related]
25. Cancer incidence and survival in kidney transplant patients.
Navarro MD; López-Andréu M; Rodríguez-Benot A; Agüera ML; Del Castillo D; Aljama P
Transplant Proc; 2008 Nov; 40(9):2936-40. PubMed ID: 19010153
[TBL] [Abstract][Full Text] [Related]
26. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
Kasiske BL; Kukla A; Thomas D; Wood Ives J; Snyder JJ; Qiu Y; Peng Y; Dharnidharka VR; Israni AK
Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332
[TBL] [Abstract][Full Text] [Related]
27. Potent immunosuppression for ABO-incompatible renal transplantation may not be a risk factor for malignancy.
Yamamoto T; Kawaguchi T; Watarai Y; Tujita M; Hiramitsu T; Nanmoku K; Goto N; Katayama A; Kobayashi T; Uchida K
Transplant Proc; 2012 Jan; 44(1):210-3. PubMed ID: 22310616
[TBL] [Abstract][Full Text] [Related]
28. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
[TBL] [Abstract][Full Text] [Related]
29. Posttransplant De Novo Hepatitis C Virus Infection in Renal Transplant Recipients: Its Impact on Morbidity and Mortality.
Hanif FM; Laeeq SM; Luck NH; Aziz T; Abbas Z; Mubarak M
Exp Clin Transplant; 2017 Feb; 15(1):56-60. PubMed ID: 27915964
[TBL] [Abstract][Full Text] [Related]
30. Outcome of Kidney Transplant in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Buttigieg J; Henderson L; Kidder D
Exp Clin Transplant; 2017 Oct; 15(5):509-515. PubMed ID: 27765007
[TBL] [Abstract][Full Text] [Related]
31. Posttransplant malignancies in liver transplant recipients.
Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818
[TBL] [Abstract][Full Text] [Related]
32. Pretransplant Cancer in Kidney Recipients in Relation to Recurrent and De Novo Cancer Incidence Posttransplantation and Implications for Graft and Patient Survival.
Unterrainer C; Opelz G; Döhler B; Süsal C;
Transplantation; 2019 Mar; 103(3):581-587. PubMed ID: 30418430
[TBL] [Abstract][Full Text] [Related]
33. Donor-recipient age difference and graft survival in living donor kidney transplantation.
Lee YJ; Chang JH; Choi HN; Jung JY; Kim YS; Chung WK; Park YH; Lee HH
Transplant Proc; 2012 Jan; 44(1):270-2. PubMed ID: 22310630
[TBL] [Abstract][Full Text] [Related]
34. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
[TBL] [Abstract][Full Text] [Related]
35. Colon Biopsy Findings of Renal Transplant Patients.
Taştepe FZ; Özgün G; Özdemir BH; Tepeoğlu M; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):78-81. PubMed ID: 27805519
[TBL] [Abstract][Full Text] [Related]
36. Incidence and Long-Term Prognosis of Cancer After Kidney Transplantation.
Pendón-Ruiz de Mier V; Navarro Cabello MD; Martínez Vaquera S; Lopez-Andreu M; Aguera Morales ML; Rodriguez-Benot A; Aljama Garcia P
Transplant Proc; 2015 Nov; 47(9):2618-21. PubMed ID: 26680052
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Risk Factors for Posttransplant Diabetes Mellitus After Kidney Transplantation: Single-Center Experience.
Gulsoy Kirnap N; Bozkus Y; Haberal M
Exp Clin Transplant; 2020 Jan; 18(Suppl 1):36-40. PubMed ID: 32008491
[TBL] [Abstract][Full Text] [Related]
38. Survival and allograft rejection rates after combined heart and kidney transplantation in comparison with heart transplantation alone.
Czer LS; Ruzza A; Vespignani R; Jordan S; De Robertis MA; Mirocha J; Gallagher SP; Patel K; Schwarz ER; Kass RM; Trento A
Transplant Proc; 2011 Dec; 43(10):3869-76. PubMed ID: 22172862
[TBL] [Abstract][Full Text] [Related]
39. Pediatric kidney transplant with laparoscopic donor nephrectomy.
Simforoosh N; Zare S; Basiri A; Tabibi A; Samzadeh M; Soltani MH
Exp Clin Transplant; 2014 Oct; 12(5):391-5. PubMed ID: 25299366
[TBL] [Abstract][Full Text] [Related]
40. Occurrence of malignancies after kidney transplantation in adults: Slovak multicenter experience.
Zilinska Z; Sersenova M; Chrastina M; Breza J; Bena L; Baltesova T; Jurcina A; Roland R; Lackova E; Cellar M; Laca L; Dedinska I
Neoplasma; 2017; 64(2):311-317. PubMed ID: 28052685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
